Light AE[au] - Search Results

Year	Number of Results
1934	1
1937	1
1947	1
1949	2
1951	2
1952	1
1953	5
1954	3
1955	3
1956	1
1957	1
1958	1
1959	1
1960	1
1967	1
1968	1
2017	1
2018	2
2019	1
2022	2
2023	2
2024	1

1

Out of sight, out of mind: When and how perceived vulnerability decreases foreseeability and responsibility for causing harm in the marketplace.

Shepherd S, Light AE. Shepherd S, et al. Among authors: light ae. J Exp Psychol Appl. 2023 Dec 25. doi: 10.1037/xap0000506. Online ahead of print. J Exp Psychol Appl. 2023. PMID: 38147048

2

Don't give up? It's a little complicated: Action Crisis Moderates Consequences of goal support.

Light AE, Chodos E. Light AE, et al. Motiv Emot. 2022;46(6):868-883. doi: 10.1007/s11031-022-09977-8. Epub 2022 Sep 20. Motiv Emot. 2022. PMID: 36160472 Free PMC article.

3

Self-Uncertainty and the Influence of Alternative Goals on Self-Regulation.

Light AE, Rios K, DeMarree KG. Light AE, et al. Pers Soc Psychol Bull. 2018 Jan;44(1):24-36. doi: 10.1177/0146167217730368. Epub 2017 Sep 21. Pers Soc Psychol Bull. 2018. PMID: 28934896

4

Perceptions, policies, and practices related to dispensing buprenorphine for opioid use disorder: A national survey of community-based pharmacists.

Hill LG, Light AE, Green TC, Burns AL, Sanaty Zadeh P, Freeman PR. Hill LG, et al. Among authors: light ae. J Am Pharm Assoc (2003). 2023 Jan-Feb;63(1):252-260.e6. doi: 10.1016/j.japh.2022.08.017. Epub 2022 Aug 24. J Am Pharm Assoc (2003). 2023. PMID: 36202711

5

Graham Lusk.

Light AE. Light AE. Yale J Biol Med. 1934 May;6(5):487.b1-506. Yale J Biol Med. 1934. PMID: 21433610 Free PMC article. No abstract available.

6

Relationships Between Stigma, Risk Tolerance, and Buprenorphine Dispensing Intentions Among Community-Based Pharmacists: Results From a National Sample.

Light AE, Green TC, Freeman PR, Zadeh PS, Burns AL, Hill LG. Light AE, et al. Subst Use Addctn J. 2024 Apr;45(2):211-221. doi: 10.1177/29767342231215178. Epub 2024 Jan 4. Subst Use Addctn J. 2024. PMID: 38258805

7

Early life trauma: An exploratory study of effects on OXTR and NR3C1 gene expression and nurturing self-efficacy in mothers of infants.

Light AE, Holt-Lunstad J, Porter CL, Light KC. Light AE, et al. Int J Psychophysiol. 2019 Feb;136:64-72. doi: 10.1016/j.ijpsycho.2018.03.018. Epub 2018 Mar 24. Int J Psychophysiol. 2019. PMID: 29580902

8

The pharmacology of No. 48-80, a long-acting vasodepressor drug.

DEWS PB, WNUCK AL, FANELLI RV, LIGHT AE, TORNABEN JA, NORTON S, ELLIS CH, DE BEER EJ. DEWS PB, et al. Among authors: light ae. J Pharmacol Exp Ther. 1953 Jan;107(1):1-11. J Pharmacol Exp Ther. 1953. PMID: 13035641 No abstract available.

9

Patterned loss of hair in man; pathogenesis and prognosis.

LIGHT AE. LIGHT AE. Ann N Y Acad Sci. 1951 Mar;53(3):729-34. doi: 10.1111/j.1749-6632.1951.tb31972.x. Ann N Y Acad Sci. 1951. PMID: 14819897 No abstract available.

10

Pharmacologic properties of cyclizine hydrochloride (marezine).

NORTON S, COLVILLE KI, LIGHT AE, WNUCK AL, FANELLI RV, DE BEER EJ. NORTON S, et al. Among authors: light ae. J Pharmacol Exp Ther. 1954 Nov;112(3):297-305. J Pharmacol Exp Ther. 1954. PMID: 13212641 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

32 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

32 results

Results by year